Pharvaris Ownership | Who Owns Pharvaris?
Pharvaris Ownership Summary
Pharvaris is owned by 79.92% institutional investors, 9.49% insiders, and 10.59% retail investors. General atlantic is the largest institutional shareholder, holding 13.99% of PHVS shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 2.30% of its assets in Pharvaris shares.
PHVS Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Pharvaris | 79.92% | 9.49% | 10.59% |
Sector | Healthcare Stocks | 46.62% | 8.13% | 45.25% |
Industry | Biotech Stocks | 44.91% | 7.98% | 47.11% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
General atlantic | 7.53M | 13.99% | $141.59M |
Fmr | 5.21M | 9.67% | $97.87M |
Foresite capital management iv | 4.29M | 7.98% | $80.72M |
Venbio partners | 4.29M | 7.97% | $80.64M |
Viking global investors lp | 3.65M | 6.79% | $68.68M |
Vr adviser | 3.40M | 6.31% | $63.84M |
Bain capital life sciences investors | 3.30M | 6.14% | $62.10M |
Commodore capital lp | 1.81M | 3.36% | $34.03M |
Novo | 1.73M | 3.21% | $32.43M |
Cormorant asset management, lp | 1.47M | 2.72% | $27.57M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Foresite capital management iv | 4.29M | 54.23% | $80.72M |
Venbio partners | 4.29M | 34.83% | $80.64M |
Bain capital life sciences investors | 3.30M | 6.82% | $62.10M |
General atlantic | 7.53M | 4.45% | $141.59M |
Vr adviser | 3.40M | 4.07% | $63.84M |
5am venture management | 797.60K | 3.35% | $14.99M |
Commodore capital lp | 1.81M | 2.32% | $34.03M |
Novo | 1.73M | 1.63% | $32.43M |
Cormorant asset management, lp | 1.47M | 1.59% | $27.57M |
Sphera funds management | 403.26K | 1.03% | $7.58M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Novo | 1.73M | 1.63% | 556.97K |
Deerfield management company, l.p. (series c) | 1.40M | 0.44% | 335.69K |
Foresite capital management iv | 4.29M | 54.23% | 255.01K |
Commodore capital lp | 1.81M | 2.32% | 85.17K |
Healthinvest partners ab | 34.33K | 0.39% | 34.33K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Cormorant asset management, lp | 1.47M | 1.59% | -245.00K |
Citadel advisors | 14.47K | 0.00% | -223.83K |
Price t rowe associates inc /md/ | 585.27K | 0.00% | -172.64K |
Walleye capital | - | - | -48.77K |
Qube research | - | - | -30.14K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Healthinvest partners ab | 34.33K | 0.39% | 34.33K | $645.37K |
Virtus etf advisers | 5.00K | 0.05% | 5.00K | $94.02K |
Wells fargo & company/mn | 700.00 | - | 700.00 | $13.16K |
Ubs group | 167.00 | - | 167.00 | $3.14K |
Sold Out
Holder | Change |
---|---|
Jpmorgan chase | -3.15K |
Jump financial | -11.70K |
Y-intercept (hong kong) | -15.88K |
Hudson bay capital management lp | -20.02K |
Qube research | -30.14K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2024 | 36 | 2.86% | 43,008,763 | 1.37% | 79 | 1.21% | 15 | -16.67% | 9 | - |
Mar 31, 2024 | 35 | -2.78% | 42,425,740 | 4.12% | 81 | 0.82% | 18 | -40.00% | 9 | 125.00% |
Dec 31, 2023 | 36 | 71.43% | 40,745,703 | 40.18% | 99 | 1.96% | 30 | 233.33% | 4 | -33.33% |
Sep 30, 2023 | 21 | - | 29,067,102 | 0.53% | 71 | 0.97% | 9 | -18.18% | 6 | 50.00% |
Jun 30, 2023 | 21 | - | 28,913,752 | 32.74% | 85 | 2.06% | 11 | 120.00% | 4 | -20.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Growth Compy Commingled Pl S | 1.24M | 2.30% | 7.16K |
Fidelity Growth Compy Commingled Pl O | 1.24M | 2.29% | - |
Fidelity Growth Company Fund | 958.28K | 1.77% | -2.04K |
Fidelity Select Health Care | 740.75K | 1.37% | - |
Fidelity Small Cap Growth | 728.09K | 1.35% | -1.91K |
Fidelity Advisor Health Care I | 478.19K | 0.89% | - |
Fidelity Growth Company K6 | 297.18K | 0.55% | -5.13K |
Fidelity Small Cap Growth K6 | 271.33K | 0.50% | 1.91K |
Fidelity Series Growth Company | 269.01K | 0.50% | - |
MEDICAL BioHealth EUR Acc | 124.89K | 0.23% | -156.86K |
PHVS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools